4/A: Confluent CEO Edward Kreps Executes Planned Stock Sale

Confluent CEO Edward Jay Kreps sold 37,707 shares of Class A Common Stock for an average price of $21.84 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Edward Jay Kreps, Chief Executive Officer and Director of Confluent, Inc. (CFLT), reported a sale of Class A Common Stock.
• The transaction involved the disposition of 37,707 shares on May 20, 2025.
• The shares were sold at an average price of $21.84 per share, with prices ranging from $21.63 to $22.00.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted on August 15, 2024.
• Following this transaction, Edward Jay Kreps beneficially owns 414,781 shares of Class A Common Stock directly.
• This Form 4/A amends and restates in its entirety the original Form 4 filed on May 22, 2025.

Sentiment

Score: 5

Explanation: The sale of shares by the CEO was conducted under a pre-arranged 10b5-1 trading plan, which is a routine liquidity event and generally viewed as neutral. It does not indicate a change in company fundamentals or management's confidence beyond the scope of the plan.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, adopted well in advance on August 15, 2024, which demonstrates transparency and adherence to insider trading regulations.
• The use of a 10b5-1 plan helps mitigate concerns about opportunistic insider selling, as the plan is established when the insider is not in possession of material non-public information.

Negatives

• While executed under a pre-arranged plan, any insider sale, particularly by a CEO, can sometimes be perceived by investors as a lack of increased confidence in the company's near-term stock price performance.

Stakeholder Impact

• Shareholders will note the sale of shares by a key executive, which is a routine disclosure for transparency purposes.

Key Dates

Recommendation

The Form 4/A filing reports a routine insider stock sale by the CEO under a pre-arranged 10b5-1 trading plan. This type of transaction is primarily for executive liquidity and diversification and typically does not reflect a change in the company's operational performance or future prospects. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Confluent, CFLT, Edward Kreps, insider trading, stock sale, 10b5-1 plan, SEC Form 4, CEO